Terry Pearson

Chief Tech/Sci/R&D Officer at Siscapa Assay Technologies, Inc.

78 year

Health Technology

Consumer Services

Consumer Non-Durables

Terry Pearson active positions

Companies	Position	Start	End
Science Council of British Columbia	Director/Board Member	01/09/2010	-
CAVA Healthcare, Inc. CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada.	Director/Board Member	-	-
Siscapa Assay Technologies, Inc. Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation.	Chief Tech/Sci/R&D Officer	-	-
Eyam Vaccines & Immunotherapeutics Ltd.	Director/Board Member	10/01/2022	-

Companies	Position	Start	End
BIOASIS TECHNOLOGIES INC.	Director/Board Member	27/03/2008	21/09/2017
BIOASIS TECHNOLOGIES INC.	Independent Dir/Board Member	27/03/2008	21/09/2017
MARKER THERAPEUTICS, INC.	Director/Board Member	-	05/12/2005
University of British Columbia	Corporate Officer/Principal	-	-
NEVIS BRANDS INC.	Director/Board Member	16/12/2014	-
NEVIS BRANDS INC.	Independent Dir/Board Member	16/12/2014	-
University of Victoria	Corporate Officer/Principal	01/01/1979	-
░░░ ░░░░░ ░░░ ░░░░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	-	-

University of British Columbia

Doctorate Degree

International

Canada	7
United States	5

Operational

Director/Board Member	7
Independent Dir/Board Member	2
Corporate Officer/Principal	2

Sectoral

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	5
Siscapa Assay Technologies, Inc. Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation.	Health Technology
CAVA Healthcare, Inc. CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada.	Consumer Non-Durables
The Terry Fox Foundation
Science Council of British Columbia
Eyam Vaccines & Immunotherapeutics Ltd.